Andrew Nguyen

发表

Endogenous T cells prevent tumor immune escape following adoptive T cell therapy.

B. Lichty, J. Bramson, K. Stephenson, 2019, The Journal of clinical investigation.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer

N. Nagarajan, M. Prlic, E. Newell, 2020, Cell reports. Medicine.

Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma

Charles J. Vaske, E. Collisson, Wei Wu, 2018, Nature Communications.

Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination

Sandeep T. Koshy, Derek L. Clouthier, Liang Zhang, 2016, The Journal of Immunology.

Prime hAd5 Spike + Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects that are Sustained Against Spike Variants

A. Rice, S. Rabizadeh, P. Soon-Shiong, 2021 .

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer

E. Turkbey, J. Schlom, A. Papanicolau‐Sengos, 2022, The Journal of clinical investigation.

HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity

Y. Wan, Lan Chen, S. Walsh, 2022, The Journal of clinical investigation.

HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants.

S. Workenhe, Jonathan G. Pol, J. Bramson, 2018, Cell reports.

Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity

J. Bell, D. Stojdl, J. Bramson, 2018, The Journal of clinical investigation.

Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy

Charles J. Vaske, M. Beckmann, P. Fasching, 2021, Journal for ImmunoTherapy of Cancer.

Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status

M. Rugge, M. Fassan, C. Szeto, 2019, Journal of Immunotherapy for Cancer.

Health Science Academy

S. Hobbs, Isabelle S. Nguyen, Andrew Nguyen, 2018 .

MS-275 (ENTINOSTAT) PROMOTES SUSTAINED TUMOR REGRESSION IN THE CONTEXT OF BOOSTING ONCOLYTIC IMMUNOTHERAPY

Andrew Nguyen, 2013 .

Immune checkpoint inhibitor cardiotoxicity: Breaking barriers in the cardiovascular immune landscape.

P. Nguyen, Sean M. Wu, Andrew Nguyen, 2021, Journal of Molecular and Cellular Cardiology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer

Y. Wan, Andrew Nguyen, L. Ho, 2014, Front. Oncol..

HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy.

Yonghong Wan, Alfredo Capretta, J. Diallo, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy

L. Rohlin, S. Benz, J. Z. Sanborn, 2019, Cancer Immunology Research.

Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study

C. Szeto, Yulia Newton, C. Nangia, 2020, Journal for ImmunoTherapy of Cancer.

De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors

Jalees A. Nasir, A. Oberst, D. Bakhshinyan, 2020, Communications Biology.

Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer.

B. Lichty, M. Atherton, K. Stephenson, 2018, Vaccine.

Customized Viral Immunotherapy for HPV-Associated Cancer

J. Diallo, S. Johnson-Obaseki, Fuan Wang, 2017, Cancer Immunology Research.

Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes.

M. Rugge, M. Fassan, J. Z. Sanborn, 2020, The oncologist.

ROBO4-Mediated Vascular Integrity Regulates the Directionality of Hematopoietic Stem Cell Trafficking

E. Forsberg, Andrew Nguyen, Stephanie Smith-Berdan, 2015, Stem cell reports.

Robo4 cooperates with CXCR4 to specify hematopoietic stem cell localization to bone marrow niches.

Dean Y. Li, J. Ciriza, E. Forsberg, 2011, Cell stem cell.

Prediction of Bene ﬁ t from Checkpoint Inhibitors in Mismatch Repair De ﬁ cient Metastatic Colorectal Cancer: Role of Tumor In ﬁ ltrating Lymphocytes

M. Rugge, L. Zapata, A. Sottoriva, 2020 .

Pathobiology

E. Richards, E. Lin, Andrew Nguyen, 2015, Laboratory Investigation.

Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma

Charles J. Vaske, E. Collisson, Wei Wu, 2018, Nature Communications.

RNA-Seq analyses of immune cell-type enrichments in 158 Asian colorectal cancers (CRCs).

Charles J. Vaske, S. Benz, C. Szeto, 2018 .

Three-fold overestimation of tumor mutation burden using 248 gene panel versus whole exome.

Shahrooz Rabizadeh, Stephen Charles Benz, S. Benz, 2018 .